Mission Hills Financial Advisory »

Fs Global Cr Opportunitie Fda shares owned by Mission Hills Financial Advisory

Quarter-by-quarter ownership of Fs Global Cr Opportunitie Fda (FSCO) shares owned by Mission Hills Financial Advisory from 13F filings

Historical chart of Mission Hills Financial Advisory investment in Fs Global Cr Opportunitie Fda

Tip: Access up to 7 years of quarterly data

All positions including Fs Global Cr Opportunitie Fda held by Mission Hills Financial Advisory consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Fs Global Cr Opportunitie Fda by Mission Hills Financial Advisory

Quarter filed Position value Share count Share price at filing
2025-12-31 $86k 14k 6.30

More positions owned by Mission Hills Financial Advisory

Vaneck Etf Trust Bdc Income Etf (BIZD)
Pimco Etf Tr Enhan Shrt Ma Ac (MINT)
PIMCO Corporate Income Fund (PCN)
Global X Fds Nasdaq 100 Cover (QYLD)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Pimco Dynamic Income SHS (PDI)
Cohen & Steers Quality Income Realty (RQI)
Invesco Exch Traded Fd Tr Ii Kbw Hig Dv Yld (KBWD)
Vanguard Tax-managed Fds Van Ftse Dev Mkt (VEA)
Schwab Strategic Tr Us Dividend Eq (SCHD)
Invesco Exch Traded Fd Tr Ii S&p 500 Revenue (RWL)
First Tr Exchange-traded Senior Ln Fd (FTSL)
Select Sector Spdr Tr State Street Con (XLY)
Vanguard Whitehall Fds Intl High Etf (VYMI)
Franklin Templeton Etf Tr Senior Loan Etf (FLBL)

View all positions for Mission Hills Financial Advisory

Top funds holding Fs Global Cr Opportunitie Fda

Commonwealth Equity Services
Cambridge Investment Research Advisors
Sit Investment Associates
Cetera Investment Advisers
LPL Financial
Vista Finance
Thomas J. Herzfeld Advisors
Blackstone Group
Envestnet Asset Management
Rockefeller Capital Management
Advisor Group Holdings
Summit Financial
Raymond James Financial
Deschutes Portfolio Strategy
Ellis Investment Partners

View all funds holding Fs Global Cr Opportunitie Fda